Veranova Relocates Headquarters to Devens, MA
Veranova is pleased to announce the move of its corporate headquarters to its Devens, Massachusetts facility, one of the company’s principal sites for manufacturing and development. Strategically located near the Boston pharmaceutical and biotech hub, Veranova’s Devens site is an FDA approved facility and a center of excellence for development through clinical and commercial manufacturing of antibody-drug conjugates (ADCs), high potent APIs, phosphoramidites and other complex small molecules. The site is currently undergoing a $30M expansion of its ADC and high potent development and manufacturing capabilities.
The investment in Devens is part of a multi-year growth strategy to build the leading development and manufacturing partner for complex synthetic pharmaceuticals, and spans our locations in West Deptford, New Jersey; North Andover, Massachusetts; Edinburgh, Scotland and Cambridge, England.
With the re-location of the corporate headquarters, Veranova will be exiting the current headquarters office in Wayne, Pennsylvania. Existing employees in Wayne will continue operating from a new location in Berwyn, Pennsylvania.
Veranova is a global leader in process development and manufacturing of APIs, with a focus on specialty and complex products. Veranova is headquartered in Devens, Massachusetts and has operations in North America and Europe.
Total Page Views: 165
